Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Michel Farnier
Based on 25 articles published since 2009
(Why 25 articles?)
||||
Expertise Level
The expertise of Michel Farnier ranks in the
  • Top 0.091%
  • ... of 27,574 published authors worldwide on Hypercholesterolemia
  • ... from 2009 through 2019
  • ... based on contributions to 25 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Farnier, M   ·   Farnier, Michel
Work Locations
Details
Most likely:    Universite de Bourgogne      
2019
  • Pitié-Salpétrière Hospital and ACTION-Group, Heart Institute, Cardiology Department, 47-83, boulevard de l'Hôpital, 75013 Paris, France. · Lipid Clinic, Point Médical, rond-point de la Nation, 21000 Dijon, France; CHU Dijon-Bourgogne, Cardiology Department, 5, boulevard Jeanne-d'Arc, 21000 Dijon, France. · AP-HP, Hôpital Européen Georges Pompidou, Cardiology Department, 20, rue Leblanc, 75015 Paris, France; Université Paris Descartes, 75015 Paris, France. · Pubmed 30853281
2018
  • LVTS, INSERM U1148, Paris, France. · Paris Diderot University, Paris7, France. · Laboratory of Biochemistry and Molecular Therapeutics (LBTM), Faculty of Pharmacy and Pôle technologie Santé (PTS), Saint-Joseph University, Beirut, Lebanon. · Department of Endocrinology and Cardiovascular Disease Prevention, AP-HP, La Pitié-Salpêtrière Hospital, ICAN, Paris, France. · Department of Biochemistry, AP-HP, La Pitié-Salpêtrière Hospital, Paris, France. · Department of Endocrinology, Nutrition and Metabolic Diseases, Hospices Civils de Lyon, Louis Pradel Cardiovascular Hospital, Bron, France. · Department of Biochemistry and Molecular Biology, Hospices Civils de Lyon, Bron, France. · Department of Cardiology and Point Médical, CHU Dijon Bourgogne, Dijon, France. · Faculty of Pharmacy, Department of Internal Medicine, University Hospital, Lille, France. · Laboratory of Biochemistry and Molecular Genetics, AP-HP, HUPIFO, Ambroise Paré Hospital, Boulogne-Billancourt, France. · UVSQ, UFR des Sciences de la Santé Simone Veil, Montigny-Le-Bretonneux, France. · Genetic Department, AP-HP, CHU Xavier Bichat, Paris, France. · LVTS, INSERM U1148, Paris, France. · Paris Diderot University, Paris7, France. · Pubmed 29374275
2017
  • a Department of Cardiology , CHU Dijon Bourgogne and Point Medical , Dijon , France. · Pubmed 29171769
  • Lipid Clinic, Point Médical, Dijon, France; Department of Cardiology, CHU Dijon Bourgogne, Dijon, France. Electronic address: · University of Edinburgh, Edinburgh, UK. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · Sanofi, Chilly-Mazarin, France. · University of Iowa, Iowa City, IA, USA. · Pubmed 28693998
Probable:    Miscellaneous institutions in Dijon      
2017
  • University of Iowa, Iowa City, Iowa. Electronic address: · Icahn School of Medicine at Mount Sinai, New York, New York. · Point Médical, Dijon, France. · Sanofi, Bridgewater, New Jersey. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 28153102
2016
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands · Duke University Medical Center, Durham, NC. · Westside Medical Associates of Los Angeles Cedars-Sinai Heart Institute, Beverly Hills, CA. · Lipid Unit, Hospital Universitario Miguel Servet, IIS Aragon, Zaragoza, Spain. · ECOGENE-21 Clinical and Translational Research Center and Department of Medicine, Université de Montréal, Chicoutimi, Quebec, Canada. · Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Sanofi, Clinical Development, R&D, Montpellier, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals Inc, Tarrytown, NY. · Lipid Clinic, Point Médical, Dijon, France. · Pubmed 27625344
  • Point Médical, Dijon, France. Electronic address: · Baylor College of Medicine, Houston, TX, USA. · Radiant Research - Phoenix SE, Chandler, AZ, USA. · Università di Palermo - Policlinico "P. Giaccone", Palermo, Italy. · Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany. · University of Dundee, Dundee, Scotland. · Regeneron Pharmaceuticals, Inc. Tarrytown, NY, USA. · Sanofi, Paris, France. · Pubmed 26638010
  • CGH Medical Center, Sterling, Illinois; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: · Department of Pharmacological and Biomolecular Sciences, University of Milan and IRCCS Multimedica, Milan, Italy. · Lipid Clinic, Point Médical, Dijon, France. · Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey. · Pubmed 27756478
2015
  • a Lipid Clinic, Point Medical , Dijon , France. · Pubmed 26563849
  • Endocrinology and Nutrition, Hôpital Laënnec, Nantes, 44035, France. · Center for Heart and Vascular Care, University of North Carolina, Chapel Hill, NC, USA. · Merck & Co, Inc., Kenilworth, NJ, USA. · Merck & Co, Inc., Kenilworth, NJ, USA. · MSD Inc., Brussels, Belgium. · Merck & Co, Inc., Kenilworth, NJ, USA. · Merck & Co, Inc., Kenilworth, NJ, USA. · Point Medical, 21000, Dijon, France. · Pubmed 25985907
2013
2011
  • Point Medical, Rond Point de la Nation, 21000 Dijon, France. Electronic address: · Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA. · Pubmed 21600523
2009
Probable:    Universite Lille      
2015
  • From the University of Iowa, Iowa City (J.G.R.) · Point Médical, Dijon (M.F.), Centre Hospitalier Universitaire de Nantes-Hôpital Nord Laennec, Saint-Herblain (M.K.), University Hospital of Lille, Lille (G. Luc), and Sanofi, Chilly-Mazarin (C.L.) - all in France · Clinique des Maladies Lipidiques de Québec, Quebec, QC, Canada (J.B.) · Università di Palermo-Policlinico P. Giaccone, Palermo, Italy (M.A.) · the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S., J.J.P.K.) · Lipid Clinic, Oslo University Hospital, Oslo (G. Langslet) · University of the Witwatersrand, Johannesburg (F.J.R.) · Cardiovascular Center of Sarasota, Sarasota (M.E.S.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida · Westside Medical Associates of Los Angeles, Beverly Hills, CA (N.E.L.) · Regeneron Pharmaceuticals, Tarrytown, NY (R.P.) · and Sanofi, Bridgewater, NJ (U.C.). · Pubmed 25773378
2011
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 25 total) written by Michel Farnier about Hypercholesterolemia:

  • [PCSK9 inhibitors: What place in the management of dyslipidemia?] 2019
  • Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia? 2018
  • Alirocumab for the treatment of hyperlipidemia in high-risk patients: an updated review. 2017
  • Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years. 2017
  • Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials. 2017
  • Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study. 2016
  • Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial. 2016
  • Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia. 2016
  • An evaluation of alirocumab for the treatment of hypercholesterolemia. 2015
  • Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey. 2015
Show List of Full Article Records
Google Searches

Learn more about Michel Farnier using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universite de Bourgogne
Miscellaneous institutions in Dijon
Universite Lille
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universite de Bourgogne
2019
  • Pitié-Salpétrière Hospital and ACTION-Group, Heart Institute, Cardiology Department, 47-83, boulevard de l'Hôpital, 75013 Paris, France. · Lipid Clinic, Point Médical, rond-point de la Nation, 21000 Dijon, France; CHU Dijon-Bourgogne, Cardiology Department, 5, boulevard Jeanne-d'Arc, 21000 Dijon, France. · AP-HP, Hôpital Européen Georges Pompidou, Cardiology Department, 20, rue Leblanc, 75015 Paris, France; Université Paris Descartes, 75015 Paris, France. · Pubmed 30853281
2018
  • LVTS, INSERM U1148, Paris, France. · Paris Diderot University, Paris7, France. · Laboratory of Biochemistry and Molecular Therapeutics (LBTM), Faculty of Pharmacy and Pôle technologie Santé (PTS), Saint-Joseph University, Beirut, Lebanon. · Department of Endocrinology and Cardiovascular Disease Prevention, AP-HP, La Pitié-Salpêtrière Hospital, ICAN, Paris, France. · Department of Biochemistry, AP-HP, La Pitié-Salpêtrière Hospital, Paris, France. · Department of Endocrinology, Nutrition and Metabolic Diseases, Hospices Civils de Lyon, Louis Pradel Cardiovascular Hospital, Bron, France. · Department of Biochemistry and Molecular Biology, Hospices Civils de Lyon, Bron, France. · Department of Cardiology and Point Médical, CHU Dijon Bourgogne, Dijon, France. · Faculty of Pharmacy, Department of Internal Medicine, University Hospital, Lille, France. · Laboratory of Biochemistry and Molecular Genetics, AP-HP, HUPIFO, Ambroise Paré Hospital, Boulogne-Billancourt, France. · UVSQ, UFR des Sciences de la Santé Simone Veil, Montigny-Le-Bretonneux, France. · Genetic Department, AP-HP, CHU Xavier Bichat, Paris, France. · LVTS, INSERM U1148, Paris, France. · Paris Diderot University, Paris7, France. · Pubmed 29374275
2017
  • a Department of Cardiology , CHU Dijon Bourgogne and Point Medical , Dijon , France. · Pubmed 29171769
  • Lipid Clinic, Point Médical, Dijon, France; Department of Cardiology, CHU Dijon Bourgogne, Dijon, France. Electronic address: · University of Edinburgh, Edinburgh, UK. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · Sanofi, Chilly-Mazarin, France. · University of Iowa, Iowa City, IA, USA. · Pubmed 28693998
Miscellaneous institutions in Dijon
2017
  • University of Iowa, Iowa City, Iowa. Electronic address: · Icahn School of Medicine at Mount Sinai, New York, New York. · Point Médical, Dijon, France. · Sanofi, Bridgewater, New Jersey. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 28153102
2016
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands · Duke University Medical Center, Durham, NC. · Westside Medical Associates of Los Angeles Cedars-Sinai Heart Institute, Beverly Hills, CA. · Lipid Unit, Hospital Universitario Miguel Servet, IIS Aragon, Zaragoza, Spain. · ECOGENE-21 Clinical and Translational Research Center and Department of Medicine, Université de Montréal, Chicoutimi, Quebec, Canada. · Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Sanofi, Clinical Development, R&D, Montpellier, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals Inc, Tarrytown, NY. · Lipid Clinic, Point Médical, Dijon, France. · Pubmed 27625344
  • Point Médical, Dijon, France. Electronic address: · Baylor College of Medicine, Houston, TX, USA. · Radiant Research - Phoenix SE, Chandler, AZ, USA. · Università di Palermo - Policlinico "P. Giaccone", Palermo, Italy. · Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany. · University of Dundee, Dundee, Scotland. · Regeneron Pharmaceuticals, Inc. Tarrytown, NY, USA. · Sanofi, Paris, France. · Pubmed 26638010
  • CGH Medical Center, Sterling, Illinois; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: · Department of Pharmacological and Biomolecular Sciences, University of Milan and IRCCS Multimedica, Milan, Italy. · Lipid Clinic, Point Médical, Dijon, France. · Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey. · Pubmed 27756478
2015
  • a Lipid Clinic, Point Medical , Dijon , France. · Pubmed 26563849
  • Endocrinology and Nutrition, Hôpital Laënnec, Nantes, 44035, France. · Center for Heart and Vascular Care, University of North Carolina, Chapel Hill, NC, USA. · Merck & Co, Inc., Kenilworth, NJ, USA. · Merck & Co, Inc., Kenilworth, NJ, USA. · MSD Inc., Brussels, Belgium. · Merck & Co, Inc., Kenilworth, NJ, USA. · Merck & Co, Inc., Kenilworth, NJ, USA. · Point Medical, 21000, Dijon, France. · Pubmed 25985907
2013
2011
  • Point Medical, Rond Point de la Nation, 21000 Dijon, France. Electronic address: · Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA. · Pubmed 21600523
2009
Universite Lille
2015
  • From the University of Iowa, Iowa City (J.G.R.) · Point Médical, Dijon (M.F.), Centre Hospitalier Universitaire de Nantes-Hôpital Nord Laennec, Saint-Herblain (M.K.), University Hospital of Lille, Lille (G. Luc), and Sanofi, Chilly-Mazarin (C.L.) - all in France · Clinique des Maladies Lipidiques de Québec, Quebec, QC, Canada (J.B.) · Università di Palermo-Policlinico P. Giaccone, Palermo, Italy (M.A.) · the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S., J.J.P.K.) · Lipid Clinic, Oslo University Hospital, Oslo (G. Langslet) · University of the Witwatersrand, Johannesburg (F.J.R.) · Cardiovascular Center of Sarasota, Sarasota (M.E.S.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida · Westside Medical Associates of Los Angeles, Beverly Hills, CA (N.E.L.) · Regeneron Pharmaceuticals, Tarrytown, NY (R.P.) · and Sanofi, Bridgewater, NJ (U.C.). · Pubmed 25773378
2011
Sanofi
2015
  • From the University of Iowa, Iowa City (J.G.R.) · Point Médical, Dijon (M.F.), Centre Hospitalier Universitaire de Nantes-Hôpital Nord Laennec, Saint-Herblain (M.K.), University Hospital of Lille, Lille (G. Luc), and Sanofi, Chilly-Mazarin (C.L.) - all in France · Clinique des Maladies Lipidiques de Québec, Quebec, QC, Canada (J.B.) · Università di Palermo-Policlinico P. Giaccone, Palermo, Italy (M.A.) · the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S., J.J.P.K.) · Lipid Clinic, Oslo University Hospital, Oslo (G. Langslet) · University of the Witwatersrand, Johannesburg (F.J.R.) · Cardiovascular Center of Sarasota, Sarasota (M.E.S.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida · Westside Medical Associates of Los Angeles, Beverly Hills, CA (N.E.L.) · Regeneron Pharmaceuticals, Tarrytown, NY (R.P.) · and Sanofi, Bridgewater, NJ (U.C.). · Pubmed 25773378
Universite de Nantes
2015
  • From the University of Iowa, Iowa City (J.G.R.) · Point Médical, Dijon (M.F.), Centre Hospitalier Universitaire de Nantes-Hôpital Nord Laennec, Saint-Herblain (M.K.), University Hospital of Lille, Lille (G. Luc), and Sanofi, Chilly-Mazarin (C.L.) - all in France · Clinique des Maladies Lipidiques de Québec, Quebec, QC, Canada (J.B.) · Università di Palermo-Policlinico P. Giaccone, Palermo, Italy (M.A.) · the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S., J.J.P.K.) · Lipid Clinic, Oslo University Hospital, Oslo (G. Langslet) · University of the Witwatersrand, Johannesburg (F.J.R.) · Cardiovascular Center of Sarasota, Sarasota (M.E.S.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida · Westside Medical Associates of Los Angeles, Beverly Hills, CA (N.E.L.) · Regeneron Pharmaceuticals, Tarrytown, NY (R.P.) · and Sanofi, Bridgewater, NJ (U.C.). · Pubmed 25773378
10 Other Locations Show
Yearly article counts 11333121712
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.